| |
| |
|
| Insider
Information: |
Templeman Thomas |
| Relationship: |
Chief Technology Officer |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
215,067 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
215,067 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
SVP, Pharmaceutical Op... |
2015-09-29 |
22,720 |
2015-09-29 |
0 |
Premium* |
|
|
Centessa Pharmaceuticals Plc |
CNTA |
Chief Technology Officer |
2023-02-01 |
192,347 |
2021-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,400 |
192,347 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2022-12-31 |
4 |
D |
$3.10 |
$9,055 |
D/D |
(2,921) |
137,329 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2022-10-03 |
4 |
S |
$3.95 |
$9,697 |
D/D |
(2,455) |
135,792 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2022-09-30 |
4 |
S |
$4.07 |
$8,147 |
D/D |
(2,003) |
138,247 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2022-09-30 |
4 |
D |
$4.25 |
$22,874 |
D/D |
(5,382) |
134,868 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
140,000 |
140,250 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Technology Officer |
• – – |
2021-06-02 |
4 |
B |
$20.00 |
$5,000 |
D/D |
250 |
250 |
2.74 |
- |
|
| MDVN |
Medivation Inc |
SVP, Pharmaceutical Operations |
• – – |
2015-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,720 |
22,720 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
